LAG3 and osteosarcoma: Second, osteosarcoma tumor cells at diagnosis did not express any checkpoint receptors and ligands except Galectin-9, and non-tumor cells were also negative for PD-1, PD-L1, and LAG-3, suggesting that these tumors may be resistant to currently available checkpoint inhibitors if used at diagnosis.